Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Lymphoma, Large-Cell, Anaplastic 6Lung Neoplasms 6Neoplasm Metastasis 5Adenocarcinoma 4Neuroblastoma 2Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Solid Tumors 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma, Alveolar 1Recurrence 1Neurofibromatosis 2 1Lymphoma, Follicular 1Granuloma, Plasma Cell 1Glioma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Castration-resistant Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Lobular 1Carcinoma, Large Cell 1Advanced Cancer 1ALK-positive NSCLC 1

Interventions

pegylated granulocyte colony-stimulating factor 1devimistat 1Topotecan 1Sunitinib 1Sirolimus 1Simvastatin 1Radiotherapy, Image-Guided 1Nivolumab 1Methotrexate 1Ifosfamide 1Hydroxychloroquine 1Granulocyte Colony-Stimulating Factor 1Epirubicin 1Doxorubicin 1Dacarbazine 1Cyclophosphamide 1Crizotinib 1Cisplatin 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sarcoma, Clear Cell × Crizotinib × Clear all
NCT01524926 2023-12-11

CREATE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
582 enrolled
LymphoidPlasma cellSarcoma

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic, Sarcoma, Clear Cell, Rhabdomyosarcoma, Alveolar, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡